ESC CVD Prevention Guidelines 2021: Improvements, Controversies, and Opportunities
The third iteration of the European Society of Cardiology (ESC) cardiovascular disease (CVD) prevention guidelines was recently released at the 2021 ESC Congress. Following on from the original guidelines of 2012 and the update of 2016, these guidelines have been developed by the task force for CVD prevention in clinical practice with representatives of the ESC and 12 medical societies.
These guidelines reiterate the complexity of current knowledge in CVD prevention, and the need to move forward to more digitalized platforms for calculation of risk.
Read more
October 2023
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers: A clinical consensus statement from the European Society of Cardiology Working Group on Coronary Pathophysiology and Micro-circulation
This clinical consensus statement from the European Society of Cardiology defines perivascular adipose tissue (PVAT) and highlights the biological mechanisms…
Read more
October 2023
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels
Abstract: Patients with coronavirus disease 2019 (COVID-19) present increased risk for ischemic cardiovascular complications up to 1 year after infection. Although…